These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 70872)
1. Antibody response to horse gamma-globulin in recipients of renal allografts: relationship with transplant crises and transplant survival. Vincent C; Revillard JP Transplantation; 1977 Aug; 24(2):141-7. PubMed ID: 70872 [TBL] [Abstract][Full Text] [Related]
2. Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients. Prin Mathieu C; Renoult E; Kennel De March A; Béné MC; Kessler M; Faure GC Nephrol Dial Transplant; 1997 Oct; 12(10):2133-9. PubMed ID: 9351078 [TBL] [Abstract][Full Text] [Related]
3. A sensitive primary immunoassay procedure for assessing the antibody response to antilymphocyte gamma-globulin in renal transplant recipients. Svehag SE; Lundgren G Transplantation; 1975 Mar; 19(3):260-2. PubMed ID: 49108 [No Abstract] [Full Text] [Related]
4. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G; Walsh G; Deshpande P; Koffman G Nephrol Dial Transplant; 2002 Jul; 17(7):1304-9. PubMed ID: 12105256 [TBL] [Abstract][Full Text] [Related]
5. Induction in human allograft recipients of unresponsiveness to anti-lymphocyte globulin. Martin CA; Condie RM; Esquenazi V; Anthone R; Anthone S; Milgrom F Immunol Invest; 1988 Jun; 17(4):265-72. PubMed ID: 3053435 [TBL] [Abstract][Full Text] [Related]
6. Experience with antilymphocyte globulin in 144 renal transplant recipients. Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849 [TBL] [Abstract][Full Text] [Related]
7. Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin. Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL J Clin Invest; 1970 Aug; 49(8):1589-95. PubMed ID: 4194090 [TBL] [Abstract][Full Text] [Related]
8. Improved compatibility of ALG therapy by application of aggregate free globulin. Ring J; Seifert J; Seiler F; Brendel W Int Arch Allergy Appl Immunol; 1976; 52(1-4):227-34. PubMed ID: 797668 [TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of cyclosporine versus antilymphocyte globulin on delayed graft function in cadaver renal transplant recipients. Michael HJ; Francos GC; Burke JF; Besarab A; Moritz M; Gillum D; Jarrell B Transplantation; 1989 Nov; 48(5):805-8. PubMed ID: 2683263 [TBL] [Abstract][Full Text] [Related]
10. Prolongation of pancreatic islet cell allograft survival by graft pretreatment with antilymphoblast globulin (ALG). Toledo-Pereyra LH; Gordon DA; MacKenzie GH Am Surg; 1982 Jun; 48(6):282-6. PubMed ID: 6805380 [TBL] [Abstract][Full Text] [Related]
11. Polymeric IgA antibody response to rabbit antithymocyte globulin in renal transplant recipients. Hiemstra PS; Baldwin WM; van der Voort EA; Paul LC; van Es LA; Daha MR Transplantation; 1988 Apr; 45(4):701-5. PubMed ID: 3282351 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study on technics of lymphocytotoxicity: lymphocytotoxicity effects of equime globulin on human antilymphocytes (ALG)]. Imperato S; Manca F; Dessi V; Gremmo A Boll Soc Ital Biol Sper; 1977 Feb; 53(4):285-91. PubMed ID: 71907 [No Abstract] [Full Text] [Related]
13. Human gamma globulin enhances the survival of renal allografts. Riggio RR; Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Haschmeyer RH; Stenzel KH; Rubin AL Proc Eur Dial Transplant Assoc; 1979; 16():426-30. PubMed ID: 95048 [TBL] [Abstract][Full Text] [Related]
14. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581 [TBL] [Abstract][Full Text] [Related]
15. Induction immunosuppression with antilymphocyte globulin or OKT3 in cadaver kidney transplantation. Results of a single institution prospective randomized trial. Hanto DW; Jendrisak MD; So SK; McCullough CS; Rush TM; Michalski SM; Phelan D; Mohanakumar T Transplantation; 1994 Feb; 57(3):377-84. PubMed ID: 8108873 [TBL] [Abstract][Full Text] [Related]
16. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation. Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728 [No Abstract] [Full Text] [Related]
17. Clinical experience with antilymphocyte-globulin in cadaveric kidney transplantation. Ahlmen J; Storm B; Brynger H; Sandberg L; Gelin LE Scand J Urol Nephrol Suppl; 1977; (42):90-3. PubMed ID: 356232 [TBL] [Abstract][Full Text] [Related]
18. Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Najarian JS; Simmons RL; Condie RM; Thompson EJ; Fryd DS; Howard RJ; Matas AJ; Sutherland DE; Ferguson RM; Schmidtke JR Ann Surg; 1976 Sep; 184(3):352-68. PubMed ID: 786192 [TBL] [Abstract][Full Text] [Related]
19. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation. Taylor HE; Ackman CF; Horowitz I Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705 [TBL] [Abstract][Full Text] [Related]
20. Current experience with renal transplantation across the ABO barrier. Nelson PW; Helling TS; Shield CF; Beck M; Bryan CF Am J Surg; 1992 Nov; 164(5):541-4; discussion 544-5. PubMed ID: 1443385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]